Skip to content

APOTEEK JACOBS

Active
Public limited companyfounded 199531 yrs activeLievevrouwestraat 36, 2520 Ranst, BelgiumKBO/BCE: BE 0454.398.775

APOTEEK JACOBS has been active since 1995 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €201k and a net result of €106k. Equity remains stable across the filed fiscal years (±2.5% per year). Its solvency ranks better than 63% of 18173 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).

Checked score

Score 2025
79 / 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100▲+2
Solvency75▼-3
Growth32=
Track record100
Bankruptcy probability, 12 months
0.4% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €15k at 30 days acceptable
Liquidity ample (current ratio 1.62 against 1.67 in 2024; short-term debt: 50.1% and cash: 20.1% of total assets), but 50.1% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Seven signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 31 years 0 40 y
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
49.9%
Return on assets
26.2%
Age of the figures
9 mo
lowers risk · Lower-risk legal form
Companies with this legal form statistically fail less often than a BV.
KBO · legal form
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 02-06-2026, 59 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
59 d early
2024
56 d early
2023
50 d early
2022
61 d early
2021
62 d early
2020
64 d early
2019
63 d early
← before the deadline after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
19-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, micro schema

Equity
€201k▲ 0.3%
2024 · €200k
2018: €366k 2019: €198k 2020: €214k 2021: €224k 2022: €233k 2023: €214k 2024: €200k
2018 → 2025
Total assets
€403k▲ 6.9%
2024 · €377k
2018: €853k 2019: €386k 2020: €336k 2021: €377k 2022: €392k 2023: €408k 2024: €377k
2018 → 2025
Net result
€106k▲ 21.8%
2024 · €87k
2018: €136k 2019: €133k 2020: €146k 2021: €113k 2022: €111k 2023: €81k 2024: €87k
2018 → 2025
Working capital
€125k▲ 5.7%
2024 · €118k
2018: €244k 2019: €85k 2020: €117k 2021: €106k 2022: €119k 2023: €115k 2024: €118k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Equity€224k-€233k▲ 3.9%€214k▼ 8.2%€200k▼ 6.2%€201k▲ 0.3%
Operating result€151k-€153k▲ 1.4%€116k▼ 24.6%€123k▲ 6.2%€146k▲ 18.5%
Net result€113k-€111k▼ 1.1%€81k▼ 27.3%€87k▲ 7.1%€106k▲ 21.8%
Turnover and EBIT margin not published: the abbreviated or micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€50k€100k€150kOperating result 2021: €151k€151kNet result 2021: €113k€113kOperating result 2022: €153k€153kNet result 2022: €111k€111kOperating result 2023: €116k€116kNet result 2023: €81k€81kOperating result 2024: €123k€123kNet result 2024: €87k€87kOperating result 2025: €146k€146kNet result 2025: €106k€106k20212022202320242025
After the dip in 2023 the operating result has climbed two years in a row; 2025 is 19% above 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €403k
Fixed assets €76k▼ 7.6%
Current assets €327k▲ 10.9%
Equity and liabilities €403k
Equity €201k▲ 0.3%
Debt €202k▲ 14.5%
The debt ratio rises from 46.8% to 50.1%. Equity and debt are higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
€162k
2024 · €139k
Cash flow
€122k
2024 · €103k
Solvency
49.9%
2024 · 53.2%
Current ratio
1.62
2024 · 1.67
Quick ratio
1.01
2024 · 1.02
Debt / equity
1.00
2024 · 0.88
ROE
52.5%
2024 · 43.2%
ROA
26.2%
2024 · 23.0%
Interest coverage
79.41
2024 · 52.23
Debt
€202k
2024 · €176k
Debt ≤ 1 year
€202k
2024 · €176k
Income taxes
€41k
2024 · €35k
Staff costs
€44k
2024 · €97k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet Code20242025
Assets
Total assets20/58€377k€403k
Fixed assets21/28€82k€76k
Tangible fixed assets22/27€80k€68k
Land and buildings22€65k€53k
Plant, machinery and equipment23€1k€5k
Furniture and vehicles24€14k€11k
Financial fixed assets28€2k€7k
Current assets29/58€295k€327k
Stocks and contracts in progress3€116k€124k
Stocks30/36€116k€124k
Amounts receivable within one year40/41€65k€118k
Trade receivables40€58k€117k
Other amounts receivable41€7k€1k
Cash at bank and in hand54/58€110k€81k
Deferred charges and accrued income490/1€4k€3k
Equity and liabilities
Total equity and liabilities10/49€377k€403k
Equity10/15€200k€201k
Contributions10/11€62k€62k=
Capital10€62k€62k=
Issued capital100€62k€62k=
Reserves13€138k€139k
Non-distributable reserves130/1€6k€6k=
Legal reserve130€6k€6k=
Distributable reserves133€132k€133k
Profit (loss) carried forward14€0€0=
Amounts payable17/49€176k€202k
Amounts payable within one year42/48€176k€202k
Trade debts44€54k€89k
Suppliers440/4€54k€89k
Taxes, remuneration and social security45€22k€7k
Taxes450/3€5k€6k
Remuneration and social security454/9€18k€1k
Other amounts payable47/48€100k€105k
Income statement Code20242025
Remuneration, social security and pensions62€97k€44k
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€16k€16k
Other operating charges640/8€5k€4k
Gross operating margin9900€241k€210k
Operating profit (loss)9901€123k€146k
Financial income75/76B€2k€2k
Recurring financial income75€2k€2k
Financial charges65/66B€3k€2k
Recurring financial charges65€3k€2k
Profit (loss) for the period before taxes9903€122k€146k
Income taxes67/77€35k€41k
Profit (loss) for the period9904€87k€106k
Profit (loss) for the period to be appropriated9905€87k€106k
Appropriation of the result
Profit (loss) to be appropriated9906€87k€106k
Transfer from equity791/2€13k€0
Transfer to equity691/2-€565
To other reserves6921-€565
Profit to be distributed694/7€100k€105k
Return on contributions (dividend)694€100k€105k

The notes to these accounts (7 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
02-06
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
2025
05-06
NBB filing Annual accounts filed
fiscal year 2024 · micro schema
2024
11-06
NBB filing Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
31-12
Financial Weakest financial yearnet €81k ▼27.3%
Net result drops to €81k, the lowest in the series; recovery starts the following year.
31-05
NBB filing Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
30-05
NBB filing Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
28-05
NBB filing Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
31-12
Financial Highest result since 2018net €146k ▲9.2%
Operating result €197k, net result €146k, both a record.
31-12
Financial Equity above €200kEq €214k ▲8%
3 profitable years in a row build equity to €214k.
29-05
NBB filing Annual accounts filed
fiscal year 2019 · abbreviated schema
2019
31-08
NBB filing Annual accounts filed
fiscal year 2018 · abbreviated schema · 31 days late
2018
28-08
NBB filing Annual accounts filed
fiscal year 2017 · abbreviated schema · 28 days late
2017
18-07
NBB filing Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
6 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Ranst · 1 establishment unit since 1995
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Lievevrouwestraat 362520 Ranst
Ground area
514 m²
Building footprint
162 m²
Volume, LiDAR
771 m³
Parcel 11035C0456/00P000, Flanders · tallest building 7.2 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
APOTEEK JACOBS
Lievevrouwestraat 36, 2520 RanstWarehousing and support activities for transportation
since 19952.071.203.782
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
11035C0456/00P000 Flanders 514 m² 1 · 162 m² 7.2 m · 2 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Public money · subsidies and aid

Flemish government

2022 to 2023 · 2 entries · 120 EUR awarded · 120 EUR paid
Year Entries awardedpaid
2023 1 0 EUR120 EUR
2022 1 120 EUR0 EUR
Schemes
Subsidie voor opleiding en advies voor kmo's en zelfstandigen (kmo-portefeuille)
2 entries · 120 EUR · 120 EUR paid · Fonds voor Innoveren en Ondernemen

Recognitions · licences · registrations

Food safety, FASFC

1 site
Ranst2.071.203.782
1 permission
Apotheek (LM>3 maand) · since 01-01-2006

Similar companies · same sector, comparable size

Of 5,223 companies in sector 47730 we hold annual accounts for 3,862. 3,564 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPublic limited company
Founded25-01-1995
Fiscal year end31-12
Activities, NACEBEL
47730Retail sale of pharmaceutical products
52310
Sources
Crossroads Bank for EnterprisesNational Bank · 31 filingsAddress and cadastre registers

Data from official sources, last processed on 19-09-2026. Scores and ratios are computed by Checked and are not a credit decision.